Raptor Pharmaceutical Corp (RPTP) financial statements (2020 and earlier)

Company profile

Business Address 7 HAMILTON LANDING
NOVATO, CA 94949
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments15715083
Cash and cash equivalents15715083
Restricted cash and investments12 
Inventory, net of allowances, customer advances and progress billings693
Inventory693
Prepaid expense 1 
Prepaid expense and other current assets4
Other undisclosed current assets17117
Total current assets:18117296
Noncurrent Assets
Property, plant and equipment862
Intangible assets, net (including goodwill)22966
Goodwill1233
Intangible assets, net (excluding goodwill)21633
Other noncurrent assets65 
Prepaid expense and other noncurrent assets4
Total noncurrent assets:2421712
TOTAL ASSETS:423189109
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities282618
Accounts payable535
Accrued liabilities231713
Employee-related liabilities 7 
Debt1290
Deferred revenue and credits  5
Other undisclosed current liabilities (6)7
Total current liabilities:402930
Noncurrent Liabilities
Long-term debt and lease obligation9911150
Long-term debt, excluding current maturities9911150
Capital lease obligations  0
Liabilities, other than long-term debt167  
Deferred tax liabilities, net0  
Business combination, contingent consideration, liability167 
Total noncurrent liabilities:26611150
Total liabilities:30614080
Stockholders' equity
Stockholders' equity attributable to parent, including:1174929
Common stock000
Additional paid in capital442307234
Accumulated other comprehensive loss(1)(0)(0)
Accumulated deficit(323)(258) 
Warrants and rights outstanding 17
Other undisclosed stockholders' equity attributable to parent (1)(212)
Total stockholders' equity:1174929
TOTAL LIABILITIES AND EQUITY:423189109

Income statement (P&L) ($ in millions)

12/31/2015
12/31/2014
12/31/2013
Revenues946917
Revenue, net946917
Cost of revenue
(Cost of Goods and Services Sold)
(13)(9)(2)
Gross profit:826015
Operating expenses(130)(100)(69)
Other undisclosed operating income  2
Operating loss:(48)(40)(52)
Nonoperating income (expense)(0)30
Investment income, nonoperating000
Foreign currency transaction gain (loss), before tax(0)00
Other nonoperating income 2 
Interest and debt expense(16)(14)(7)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(0)104128
Income (loss) from continuing operations before equity method investments, income taxes:(65)5269
Other undisclosed loss from continuing operations before income taxes (105) 
Income (loss) from continuing operations before income taxes:(65)(52)69
Income tax expense (benefit)0(0) 
Net income (loss):(64)(53)69
Other undisclosed net loss attributable to parent(1) (139)
Net loss available to common stockholders, diluted:(65)(53)(69)

Comprehensive Income ($ in millions)

12/31/2015
12/31/2014
12/31/2013
Net income (loss):(64)(53)69
Other comprehensive income (loss)(1)0 
Comprehensive income (loss):(66)(52)69
Other undisclosed comprehensive loss, net of tax, attributable to parent(1) (139)
Comprehensive loss, net of tax, attributable to parent:(67)(52)(70)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: